Summary
356.17 0.98(0.28%)05/17/2024
Humana Inc. (HUM)
Humana Inc. (HUM)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 1.74 | 7.53 | 2.52 | -11.88 | -34.80 | -39.17 | 36.63 | 16,471.43 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 324.80 | |
| Open | 318.31 | |
| High | 324.98 | |
| Low | 318.31 | |
| Volume | 864,650 | |
| Change | 5.57 | |
| Change % | 1.74 | |
| Avg Volume (20 Days) | 1,486,156 | |
| Volume/Avg Volume (20 Days) Ratio | 0.58 | |
| 52 Week Range | 298.61 - 541.21 | |
| Price vs 52 Week High | -39.99% | |
| Price vs 52 Week Low | 8.77% | |
| Range | 2.04 | |
| Gap Up/Down | -4.58 | |
Fundamentals | ||
| Market Capitalization (Mln) | 42,808 | |
| EBIDTA | 4,472,000,000 | |
| PE Ratio | 20.6644 | |
| PEG Ratio | 1.6395 | |
| WallStreet Target Price | 362.64 | |
| Book Value | 133.8580 | |
| Earnings Per Share | 16.2400 | |
| EPS Estimate Current Quarter | 6.1200 | |
| EPS Estimate Next Quarter | 5.8100 | |
| EPS Estimate Current Year | 16.3900 | |
| EPS Estimate Next Year | 20.2700 | |
| Diluted EPS (TTM) | 16.2400 | |
| Revenues | ||
| Profit Marging | 0.0182 | |
| Operating Marging (TTM) | 0.0427 | |
| Return on asset (TTM) | 0.0491 | |
| Return on equity (TTM) | 0.1210 | |
| Revenue TTM | 109,242,998,784 | |
| Revenue per share TTM | 889.1720 | |
| Quarterly Revenue Growth (YOY) | 0.1070 | |
| Quarterly Earnings Growth (YOY) | -0.3810 | |
| Gross Profit (TTM) | 17,180,000,000 | |
| Dividends | ||
| Dividend Share | 3.5400 | |
| Dividend Yield | 0.0105 | |
| Valuations | ||
| Trailing PE | 20.6644 | |
| Forward PE | 19.3798 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 2.3172 | |
| Revenue Enterprise Value | 0.4230 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 120,501,000 | |
| Shares Float | 120,082,498 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.03 | |
| Insider (%) | 0.21 | |
| Institutions (%) | 96.41 | |
05/16 09:47 EST - businesswire.com
Humana & Privia Medical Group–Georgia Partner with Bamboo Health to Earn KLAS Research Points of Light Award
LOUISVILLE, Ky. & BOSTON--(BUSINESS WIRE)--Lack of real-time data can present serious barriers to care coordination for patients after they leave the hospital. That challenge was the motivation for an innovative collaboration between Bamboo Health™, the leader in Real-Time Care Intelligence™, Humana and Privia Medical Group (PMG)–Georgia to bridge care gaps for patients enrolled in Medicare Advantage plans. The program was one of only 22 presentations selected for a Points of Light Award on May.
Humana & Privia Medical Group–Georgia Partner with Bamboo Health to Earn KLAS Research Points of Light Award
LOUISVILLE, Ky. & BOSTON--(BUSINESS WIRE)--Lack of real-time data can present serious barriers to care coordination for patients after they leave the hospital. That challenge was the motivation for an innovative collaboration between Bamboo Health™, the leader in Real-Time Care Intelligence™, Humana and Privia Medical Group (PMG)–Georgia to bridge care gaps for patients enrolled in Medicare Advantage plans. The program was one of only 22 presentations selected for a Points of Light Award on May.
05/15 13:00 EST - businesswire.com
CenterWell Specialty Pharmacy Wins National Patient Choice Award
LOUISVILLE, Ky.--(BUSINESS WIRE)--CenterWell Specialty Pharmacy wins national patient choice award for the sixth time in seven years.
CenterWell Specialty Pharmacy Wins National Patient Choice Award
LOUISVILLE, Ky.--(BUSINESS WIRE)--CenterWell Specialty Pharmacy wins national patient choice award for the sixth time in seven years.
05/15 08:43 EST - businesswire.com
Humana Ranks 6th Overall in Fair360 National Companies for Diversity
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) has ascended to No. 6 on Fair360's prestigious list of the Top 50 Companies for Workplace Fairness, marking its seventh consecutive year in the top rankings. This significant move up from No. 10 last year showcases Humana's dedication to diversity and inclusion, as recognized by one of the nation's most comprehensive analyses of corporate diversity practices. “Providing high-quality care for our customers is centered on our understanding.
Humana Ranks 6th Overall in Fair360 National Companies for Diversity
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) has ascended to No. 6 on Fair360's prestigious list of the Top 50 Companies for Workplace Fairness, marking its seventh consecutive year in the top rankings. This significant move up from No. 10 last year showcases Humana's dedication to diversity and inclusion, as recognized by one of the nation's most comprehensive analyses of corporate diversity practices. “Providing high-quality care for our customers is centered on our understanding.
05/13 16:30 EST - businesswire.com
Jim Rechtin to Assume Humana CEO Role Effective July 1, 2024
LOUISVILLE, Ky.--(BUSINESS WIRE)--Leading health insurer and health care services company Humana Inc. (NYSE: HUM) announced today that Jim Rechtin will assume the role of President and Chief Executive Officer effective July 1, 2024. As previously announced, Rechtin joined Humana as President and Chief Operating Officer in January as part of a long-planned CEO transition. Since then, he has worked in close partnership with Humana's current CEO, Bruce Broussard, and has immersed himself in Humana.
Jim Rechtin to Assume Humana CEO Role Effective July 1, 2024
LOUISVILLE, Ky.--(BUSINESS WIRE)--Leading health insurer and health care services company Humana Inc. (NYSE: HUM) announced today that Jim Rechtin will assume the role of President and Chief Executive Officer effective July 1, 2024. As previously announced, Rechtin joined Humana as President and Chief Operating Officer in January as part of a long-planned CEO transition. Since then, he has worked in close partnership with Humana's current CEO, Bruce Broussard, and has immersed himself in Humana.
05/09 07:00 EST - seekingalpha.com
Invest Smart: 2 Blue Chips To Buy When Others Are Scared
Invest Smart: 2 Blue Chips To Buy When Others Are Scared
Invest Smart: 2 Blue Chips To Buy When Others Are Scared
Invest Smart: 2 Blue Chips To Buy When Others Are Scared
05/03 10:46 EST - zacks.com
4 HMO Stocks to Watch Amid Persistent Industry Challenges
The Medical-HMO industry continues to witness an expanding customer base resulting from contract wins. However, high technology expenses and a shortage of medical personnel are a concern.
4 HMO Stocks to Watch Amid Persistent Industry Challenges
The Medical-HMO industry continues to witness an expanding customer base resulting from contract wins. However, high technology expenses and a shortage of medical personnel are a concern.
05/02 16:15 EST - businesswire.com
Humana Inc. to Present at B of A Securities Health Care Conference 2024
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at B of A Securities Health Care Conference on Tuesday, May 14, 2024, at 8:00 a.m. Pacific time. A live audio webcast of the presentation will be available via Humana's Investor Relations page at humana.com. The company suggests webcast participants sign on approximately 15 minutes in adva.
Humana Inc. to Present at B of A Securities Health Care Conference 2024
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at B of A Securities Health Care Conference on Tuesday, May 14, 2024, at 8:00 a.m. Pacific time. A live audio webcast of the presentation will be available via Humana's Investor Relations page at humana.com. The company suggests webcast participants sign on approximately 15 minutes in adva.
05/01 10:01 EST - zacks.com
Investors Heavily Search Humana Inc. (HUM): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Humana (HUM). This makes it worthwhile to examine what the stock has in store.
Investors Heavily Search Humana Inc. (HUM): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Humana (HUM). This makes it worthwhile to examine what the stock has in store.
05/01 07:15 EST - marketbeat.com
Humana Leaves Shareholders in Limbo on 2025 EPS Guidance
Health insurer Humana Inc. NYSE: HUM reported its Q1 2024 earnings report to a less dramatic reaction than it got from its Q4 2023 report, causing shares to tumble more than 13%. Investors are still reeling over its vastly lowered EPS guidance stretching out to 2025.
Humana Leaves Shareholders in Limbo on 2025 EPS Guidance
Health insurer Humana Inc. NYSE: HUM reported its Q1 2024 earnings report to a less dramatic reaction than it got from its Q4 2023 report, causing shares to tumble more than 13%. Investors are still reeling over its vastly lowered EPS guidance stretching out to 2025.
04/30 06:15 EST - investorplace.com
3 Dirt-Cheap Health Stocks to Buy on Weakness
Some of the managed care stocks have been beaten down quite badly in recent months, thanks in part to choppy industry dynamics. Indeed, swift policy shifts (lower Medicare rates), cybersecurity breaches and loftier medical costs will certainly cause quite a bit of industry-wide volatility.
3 Dirt-Cheap Health Stocks to Buy on Weakness
Some of the managed care stocks have been beaten down quite badly in recent months, thanks in part to choppy industry dynamics. Indeed, swift policy shifts (lower Medicare rates), cybersecurity breaches and loftier medical costs will certainly cause quite a bit of industry-wide volatility.
04/25 11:20 EST - businesswire.com
Humana Healthy Horizons Commits $500K to Improve Health of Louisianians
BATON ROUGE, La.--(BUSINESS WIRE)--Humana Healthy Horizons commits $500,000 to improve the health of Louisianians.
Humana Healthy Horizons Commits $500K to Improve Health of Louisianians
BATON ROUGE, La.--(BUSINESS WIRE)--Humana Healthy Horizons commits $500,000 to improve the health of Louisianians.
04/24 19:15 EST - fool.com
Why Humana Stock Withered on Wednesday
The sell-off confirms that market players trade on future potential, not trailing results. The big insurer delivered an estimates-beating first quarter, but its profitability guidance left something to be desired.
Why Humana Stock Withered on Wednesday
The sell-off confirms that market players trade on future potential, not trailing results. The big insurer delivered an estimates-beating first quarter, but its profitability guidance left something to be desired.
04/24 13:56 EST - zacks.com
Humana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)
Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Humana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)
Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
04/24 13:50 EST - zacks.com
Premium Growth Propels Humana (HUM) to Easy Q1 Earnings Beat
Humana (HUM) bumps up individual Medicare Advantage membership growth guidance.
Premium Growth Propels Humana (HUM) to Easy Q1 Earnings Beat
Humana (HUM) bumps up individual Medicare Advantage membership growth guidance.
04/24 13:40 EST - investopedia.com
Humana Pulls 2025 Earnings Guidance on Slowing Government Medicare Funding
Humana (HUM) shares fell more than 5% in intraday trading Wednesday after it pulled its 2025 adjusted earnings guidance due to slower government healthcare spending.
Humana Pulls 2025 Earnings Guidance on Slowing Government Medicare Funding
Humana (HUM) shares fell more than 5% in intraday trading Wednesday after it pulled its 2025 adjusted earnings guidance due to slower government healthcare spending.
04/24 12:49 EST - seekingalpha.com
Humana, Inc. (HUM) Q1 2024 Earnings Call Transcript
Humana, Inc. (NYSE:HUM ) Q1 2024 Earnings Conference Call April 24, 2024 9:00 AM ET Company Participants Lisa Stoner - VP, IR Bruce Broussard - CEO & Director James Rechtin - President & COO Susan Diamond - CFO Conference Call Participants Ann Hynes - Mizuho Securities Kevin Fischbeck - Bank of America Merrill Lynch Gary Taylor - TD Cowen Scott Fidel - Stephens Benjamin Hendrix - RBC Capital Markets Nathan Rich - Goldman Sachs Group Stephen Baxter - Wells Fargo Securities Lisa Gill - JPMorgan Chase & Co. Andrew Mok - Barclays Joshua Raskin - Nephron Research Justin Lake - Wolfe Research Lance Wilkes - Sanford C. Bernstein & Co. A.J.
Humana, Inc. (HUM) Q1 2024 Earnings Call Transcript
Humana, Inc. (NYSE:HUM ) Q1 2024 Earnings Conference Call April 24, 2024 9:00 AM ET Company Participants Lisa Stoner - VP, IR Bruce Broussard - CEO & Director James Rechtin - President & COO Susan Diamond - CFO Conference Call Participants Ann Hynes - Mizuho Securities Kevin Fischbeck - Bank of America Merrill Lynch Gary Taylor - TD Cowen Scott Fidel - Stephens Benjamin Hendrix - RBC Capital Markets Nathan Rich - Goldman Sachs Group Stephen Baxter - Wells Fargo Securities Lisa Gill - JPMorgan Chase & Co. Andrew Mok - Barclays Joshua Raskin - Nephron Research Justin Lake - Wolfe Research Lance Wilkes - Sanford C. Bernstein & Co. A.J.
04/24 11:41 EST - proactiveinvestors.com
Humana shares fall as medical insurer withdraws 2025 profit guidance
Humana (NYSE:HUM) shares fell after it pulled its 2025 profit guidance, reigniting investor concerns about the impact of rising medical costs on the insurer's bottom line. Humana (NYSE:HUM) in January downgraded its 2025 profit forecast from $37 per share to between $22 to $26 per share upon the expectation it would see a rise in medical claims as patients undergo non-urgent surgeries delayed due to the pandemic.
Humana shares fall as medical insurer withdraws 2025 profit guidance
Humana (NYSE:HUM) shares fell after it pulled its 2025 profit guidance, reigniting investor concerns about the impact of rising medical costs on the insurer's bottom line. Humana (NYSE:HUM) in January downgraded its 2025 profit forecast from $37 per share to between $22 to $26 per share upon the expectation it would see a rise in medical claims as patients undergo non-urgent surgeries delayed due to the pandemic.
04/24 10:36 EST - zacks.com
Humana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Humana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.